However, leptin resistance observed in obese individuals potentially disqualifies leptin therapies as a cure to the obesity and type 2 diabetes epidemic (Coppari and Bjørbæk, 2012; Neill, 2013). The gene discussed is LEP; the disease is type 2 diabetes mellitus.